Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

World News: . []

SAN DIEGO Dec 06 2018 GLOBE NEWSWIRE -- Dar Bioscience Inc NASDAQ DARE a leader in clinical-stage womens health innovation today announced that it has entered into definitive agreements with Hammock Pharmaceuticals Inc TriLogic Pharma...

More news and information about Dare Bioscience, Inc.

Published By:

Globe Newswire: 13:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "bioscience" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us